Xtl Biopharmaceuticals (XTLB) Cash from Operations Growth (5y) (2014 - 2016)
Xtl Biopharmaceuticals (XTLB) Cash from Operations Growth (5y) (2014 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Xtl Biopharmaceuticals | 2.51 Bn | 2.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -8.75% |
| Dec 31, 2015 | 73.06% |
| Sep 30, 2015 | -15.95% |
| Jun 30, 2015 | -36.37% |
| Dec 31, 2014 | -30.33% |
| Sep 30, 2014 | -14.13% |
| Jun 30, 2014 | -36.69% |
| Mar 31, 2014 | 9.67% |